ENTA
HEALTHYENANTA PHARMACEUTICALS INC
CIK: 0001177648
Sell
(70% confidence)
Last activity: Dec 5, 2025
Financial Metrics
As of Sep 30, 2025 (10-K)
Revenue $205.20M
Net Income -$3.16M
Total Cash $32.30M
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Luly Jay R. President and CEO | 0 | 1 | -$67K | 858,026 shares $12.21M |
| Or Yat Sun Chief Scientific Officer | 0 | 1 | -$34K | 371,392 shares $5.28M |
| Kieffer Tara Lynn Chief Product Strategy Officer | 0 | 1 | -$30K | 30,620 shares $436K |
| Luu Brendan Chief Business Officer | 0 | 1 | -$20K | 38,329 shares $545K |
| Trout Harry R. III See Remarks | 0 | 2 | -$13K | 16,348 shares $233K |
| Rottinghaus Scott T. Chief Medical Officer | 0 | 1 | -$11K | 21,792 shares $310K |
| Capps Kathleen S. See Remarks | 0 | 2 | -$7K | 8,377 shares $119K |
Recent Transactions
SELL Luly Jay R. (President and CEO)
4,743 shares @ $14.23
$67K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Or Yat Sun (Chief Scientific Officer)
2,390 shares @ $14.23
$34K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Kieffer Tara Lynn (Chief Product Strategy Officer)
2,106 shares @ $14.23
$30K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Luu Brendan (Chief Business Officer)
1,394 shares @ $14.23
$20K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Rottinghaus Scott T. (Chief Medical Officer)
798 shares @ $14.23
$11K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Trout Harry R. III (See Remarks)
542 shares @ $14.23
$8K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Capps Kathleen S. (See Remarks)
323 shares @ $14.23
$5K
Dec 5, 2025
Conviction: |
View SEC Filing →
SELL Trout Harry R. III (See Remarks)
380 shares @ $13.96
$5K
Dec 2, 2025
Conviction: |
View SEC Filing →
SELL Capps Kathleen S. (See Remarks)
207 shares @ $13.96
$3K
Dec 2, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.